Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7489361.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As a result of bioassay-guided fractionation, betulinic acid, a pentacyclic triterpene, was identified as a melanoma-specific cytotoxic agent. In follow-up studies conducted with athymic mice carrying human melanomas, tumour growth was completely inhibited without toxicity. As judged by a variety of cellular responses, antitumour activity was mediated by the induction of apoptosis. Betulinic acid is inexpensive and available in abundant supply from common natural sources, notably the bark of white birch trees. The compound is currently undergoing preclinical development for the treatment or prevention of malignant melanoma.
Medical subject headings
- Antineoplastic Agents, Phytogenic
- DNA Damage
- Growth Inhibitors
- Melanoma
- Triterpenes